Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells

Debora L. Kramer, Slavoljub Vujcic, Paula Diegelman, James Alderfer, John T. Miller, Jennifer D Black, Raymond J. Bergeron, Carl W. Porter

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Although polyamines are well recognized for their critical involvement in cell growth, the cell cycle specificity of this requirement has not yet been characterized with respect to the newly delineated regulatory pathways. We recently reported that polyamine analogues having close structural and functional similarities to the natural polyamines produce a distinct G1 and G2-M cell arrest in MALME-3M human melanoma cells. To determine a molecular basis for this observation, we examined the effects of N1,N11- diethylnorspermine on cell cycle regulatory proteins associated with G1 arrest. The analogue is known to deplete polyamine pools by suppressing biosynthetic enzymes and potently inducing the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Treatment of MALME-3M cells with 10 μM N1,N11-diethylnorspermine caused an increase in hypophosphorylated Rb, which correlated temporally with the onset of G1 arrest of 16-24 h. Rb hypophosphorylation was preceded by an increase in wild-type p53 (~10-fold at maximum) and a concomitant increase in the cyclin-dependent kinase inhibitor, p21(WAF1/CIP1) (p21; ~5-fold at maximum). Another cyclin- dependent kinase inhibitor, p27(KIP1), and cyclin D1 increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged. Induction of p21 protein was accompanied by an increase in p21 mRNA, whereas induction of p53 protein was not, suggesting transcriptional activation of the former and posttranscriptional regulation of the latter. SK-MEL-28 human melanoma cells, which contain a mutated p53, failed to induce p53 or p21 and did not arrest in G1. Rather, these cells rapidly underwent programmed cell death within 48 h. Overall, these findings provide the first indication of the cell cycle regulatory pathways by which polyamine antagonists such as analogues might inhibit growth in cells containing wild-type p53 and further suggest a mechanistic basis for differential cellular responses to these agents.

Original languageEnglish (US)
Pages (from-to)1278-1286
Number of pages9
JournalCancer Research
Volume59
Issue number6
StatePublished - Mar 15 1999

Fingerprint

Polyamines
Melanoma
Cell Cycle
Cyclin-Dependent Kinase Inhibitor p21
Cyclin-Dependent Kinase Inhibitor p27
Cell Cycle Proteins
Spermine
Cyclin D1
Proliferating Cell Nuclear Antigen
Enzymes
Growth
Transcriptional Activation
Proteins
Cell Death
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Kramer, D. L., Vujcic, S., Diegelman, P., Alderfer, J., Miller, J. T., Black, J. D., ... Porter, C. W. (1999). Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells. Cancer Research, 59(6), 1278-1286.

Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells. / Kramer, Debora L.; Vujcic, Slavoljub; Diegelman, Paula; Alderfer, James; Miller, John T.; Black, Jennifer D; Bergeron, Raymond J.; Porter, Carl W.

In: Cancer Research, Vol. 59, No. 6, 15.03.1999, p. 1278-1286.

Research output: Contribution to journalArticle

Kramer, DL, Vujcic, S, Diegelman, P, Alderfer, J, Miller, JT, Black, JD, Bergeron, RJ & Porter, CW 1999, 'Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells', Cancer Research, vol. 59, no. 6, pp. 1278-1286.
Kramer DL, Vujcic S, Diegelman P, Alderfer J, Miller JT, Black JD et al. Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells. Cancer Research. 1999 Mar 15;59(6):1278-1286.
Kramer, Debora L. ; Vujcic, Slavoljub ; Diegelman, Paula ; Alderfer, James ; Miller, John T. ; Black, Jennifer D ; Bergeron, Raymond J. ; Porter, Carl W. / Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells. In: Cancer Research. 1999 ; Vol. 59, No. 6. pp. 1278-1286.
@article{2ceb2d5003bf4eac917d9b19e26faaf4,
title = "Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells",
abstract = "Although polyamines are well recognized for their critical involvement in cell growth, the cell cycle specificity of this requirement has not yet been characterized with respect to the newly delineated regulatory pathways. We recently reported that polyamine analogues having close structural and functional similarities to the natural polyamines produce a distinct G1 and G2-M cell arrest in MALME-3M human melanoma cells. To determine a molecular basis for this observation, we examined the effects of N1,N11- diethylnorspermine on cell cycle regulatory proteins associated with G1 arrest. The analogue is known to deplete polyamine pools by suppressing biosynthetic enzymes and potently inducing the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Treatment of MALME-3M cells with 10 μM N1,N11-diethylnorspermine caused an increase in hypophosphorylated Rb, which correlated temporally with the onset of G1 arrest of 16-24 h. Rb hypophosphorylation was preceded by an increase in wild-type p53 (~10-fold at maximum) and a concomitant increase in the cyclin-dependent kinase inhibitor, p21(WAF1/CIP1) (p21; ~5-fold at maximum). Another cyclin- dependent kinase inhibitor, p27(KIP1), and cyclin D1 increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged. Induction of p21 protein was accompanied by an increase in p21 mRNA, whereas induction of p53 protein was not, suggesting transcriptional activation of the former and posttranscriptional regulation of the latter. SK-MEL-28 human melanoma cells, which contain a mutated p53, failed to induce p53 or p21 and did not arrest in G1. Rather, these cells rapidly underwent programmed cell death within 48 h. Overall, these findings provide the first indication of the cell cycle regulatory pathways by which polyamine antagonists such as analogues might inhibit growth in cells containing wild-type p53 and further suggest a mechanistic basis for differential cellular responses to these agents.",
author = "Kramer, {Debora L.} and Slavoljub Vujcic and Paula Diegelman and James Alderfer and Miller, {John T.} and Black, {Jennifer D} and Bergeron, {Raymond J.} and Porter, {Carl W.}",
year = "1999",
month = "3",
day = "15",
language = "English (US)",
volume = "59",
pages = "1278--1286",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Polyamine analogue induction of the p53-p21(WAF1/CIP1)-Rb pathway and G1 Ar in human melanoma cells

AU - Kramer, Debora L.

AU - Vujcic, Slavoljub

AU - Diegelman, Paula

AU - Alderfer, James

AU - Miller, John T.

AU - Black, Jennifer D

AU - Bergeron, Raymond J.

AU - Porter, Carl W.

PY - 1999/3/15

Y1 - 1999/3/15

N2 - Although polyamines are well recognized for their critical involvement in cell growth, the cell cycle specificity of this requirement has not yet been characterized with respect to the newly delineated regulatory pathways. We recently reported that polyamine analogues having close structural and functional similarities to the natural polyamines produce a distinct G1 and G2-M cell arrest in MALME-3M human melanoma cells. To determine a molecular basis for this observation, we examined the effects of N1,N11- diethylnorspermine on cell cycle regulatory proteins associated with G1 arrest. The analogue is known to deplete polyamine pools by suppressing biosynthetic enzymes and potently inducing the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Treatment of MALME-3M cells with 10 μM N1,N11-diethylnorspermine caused an increase in hypophosphorylated Rb, which correlated temporally with the onset of G1 arrest of 16-24 h. Rb hypophosphorylation was preceded by an increase in wild-type p53 (~10-fold at maximum) and a concomitant increase in the cyclin-dependent kinase inhibitor, p21(WAF1/CIP1) (p21; ~5-fold at maximum). Another cyclin- dependent kinase inhibitor, p27(KIP1), and cyclin D1 increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged. Induction of p21 protein was accompanied by an increase in p21 mRNA, whereas induction of p53 protein was not, suggesting transcriptional activation of the former and posttranscriptional regulation of the latter. SK-MEL-28 human melanoma cells, which contain a mutated p53, failed to induce p53 or p21 and did not arrest in G1. Rather, these cells rapidly underwent programmed cell death within 48 h. Overall, these findings provide the first indication of the cell cycle regulatory pathways by which polyamine antagonists such as analogues might inhibit growth in cells containing wild-type p53 and further suggest a mechanistic basis for differential cellular responses to these agents.

AB - Although polyamines are well recognized for their critical involvement in cell growth, the cell cycle specificity of this requirement has not yet been characterized with respect to the newly delineated regulatory pathways. We recently reported that polyamine analogues having close structural and functional similarities to the natural polyamines produce a distinct G1 and G2-M cell arrest in MALME-3M human melanoma cells. To determine a molecular basis for this observation, we examined the effects of N1,N11- diethylnorspermine on cell cycle regulatory proteins associated with G1 arrest. The analogue is known to deplete polyamine pools by suppressing biosynthetic enzymes and potently inducing the polyamine catabolic enzyme spermidine/spermine N1-acetyltransferase. Treatment of MALME-3M cells with 10 μM N1,N11-diethylnorspermine caused an increase in hypophosphorylated Rb, which correlated temporally with the onset of G1 arrest of 16-24 h. Rb hypophosphorylation was preceded by an increase in wild-type p53 (~10-fold at maximum) and a concomitant increase in the cyclin-dependent kinase inhibitor, p21(WAF1/CIP1) (p21; ~5-fold at maximum). Another cyclin- dependent kinase inhibitor, p27(KIP1), and cyclin D1 increased slightly, whereas proliferating cell nuclear antigen and p130 remained unchanged. Induction of p21 protein was accompanied by an increase in p21 mRNA, whereas induction of p53 protein was not, suggesting transcriptional activation of the former and posttranscriptional regulation of the latter. SK-MEL-28 human melanoma cells, which contain a mutated p53, failed to induce p53 or p21 and did not arrest in G1. Rather, these cells rapidly underwent programmed cell death within 48 h. Overall, these findings provide the first indication of the cell cycle regulatory pathways by which polyamine antagonists such as analogues might inhibit growth in cells containing wild-type p53 and further suggest a mechanistic basis for differential cellular responses to these agents.

UR - http://www.scopus.com/inward/record.url?scp=0033559550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033559550&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 1278

EP - 1286

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 6

ER -